ÂÜÀòÂÒÂ×

Carl St. Bernard currently serves as the Chief Executive Officer of Jupiter Endovascular since July 2024. In addition, Carl holds board member positions at Transverse Medical Inc and AdvaMed, both established in March 2021, and served as President and CEO of ALTA Biomaterials from January 2023 to June 2024. Previously, Carl was President & CEO of CeloNova BioSciences, Inc. from August 2019 to January 2023, and President & CEO of Tryton from December 2017 to June 2019. Carl has also held various leadership roles at Johnson & Johnson Vision Care, Inc., LifeCell Corporation, and DePuy Synthes Companies of Johnson & Johnson. Academic qualifications include an MBA in Business from Pepperdine Graziadio Business School and an Executive Leadership Program from Northwestern University - Kellogg School of Management, along with a B.A. in Economics and Business from Lafayette College.